The detailed mechanism of inhibiting migration and invasion by nevirapine in dedifferentiated thyroid cancer cells was not performed in our study, but the next part of our work will be to explore in depth how nevirapine works to inhibit migration and invasion by IL‐3/STAT3 pathway. The gene discussed is IL3; the disease is thyroid gland carcinoma.